View Document Preview and Link Document Date: 2013-01-18 05:17:24 Open Document File Size: 560,21 KB Share Result on Facebook
Company Agency for Healthcare Research / / Country United States / / Facility Baylor College of Medicine / AHRQ Pub / / IndustryTerm his/her insurance coverage / treatment for hepatitis C / treatment for HCV / / MedicalCondition Autoimmune disorders / neoplasms / Hemolytic anemia / insulin resistance / cardiovascular disorders / HIV / Patients Treating Chronic Hepatitis C / disease / Clinician Research Summary Infectious Diseases / HCV genotype 1 / liver failure / acute HCV infection / baseline liver disease / dysgeusia / chronic HCV / progressive disease / neutropenia / cirrhosis / thrombocytopenia / hepatocellular cancer / hepatitis C / HCV / viremia / Ischemic disorders / fatal and nonfatal myocardial infarctions / severe anemia / HCV infection / psychiatric disorders / Virus Infection / severe rash / Advanced fibrosis / cardiac disease / infection / Chronic HCV infection / liver disease / HCV genotype 2 / infections / rash / gastrointestinal disorders / Infectious disorders / chronic HCV infections / anemia / chronic hepatitis C / severe neutropenia / fibrosis / HCV genotype / HCV RNA / / MedicalTreatment antiviral therapies / hemodialysis / antiviral therapy / / Organization Baylor College of Medicine / Houston / U.S. Food and Drug Administration / Oregon Evidence-based Practice Center / John M. Eisenberg Center for Clinical Decisions and Communications Science / Agency for Healthcare Research and Quality / / / Product ribavirin / Virus Infection‡ Medication / / PublishedMedium the Annals of Internal Medicine / / Technology antibodies / transplantation / genotype / / URL www.effectivehealthcare.ahrq.gov/hepctreatment.cfm / www.fda.gov / www.cdc.gov/hepatitis/HCV / www.effectivehealthcare.ahrq.gov / / 
Clinician Research Summary Infectious Diseases and HIV/AIDS Hepatitis C Comparative Effectiveness of Treatments for Chronic